|
LRRC37B2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.584100E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.271600E-02 |
| Normal-vs-Stage2 |
3.086800E-01 |
| Normal-vs-Stage3 |
8.764000E-01 |
| Normal-vs-Stage4 |
5.894000E-02 |
| Stage1-vs-Stage2 |
9.806600E-01 |
| Stage1-vs-Stage3 |
2.717400E-01 |
| Stage1-vs-Stage4 |
8.180000E-01 |
| Stage2-vs-Stage3 |
3.912800E-01 |
| Stage2-vs-Stage4 |
8.153000E-01 |
| Stage3-vs-Stage4 |
2.572600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.367500E-02 |
| Normal-vs-AfricanAmerican |
4.667600E-02 |
| Normal-vs-Asian |
4.549600E-01 |
| Caucasian-vs-AfricanAmerican |
7.040600E-01 |
| Caucasian-vs-Asian |
8.935600E-01 |
| AfricanAmerican-vs-Asian |
9.992400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.354000E-01 |
| Normal-vs-Female |
4.443900E-04 |
| Male-vs-Female |
6.303400E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
5.570000E-01 |
| Normal-vs-Extreme_Weight |
2.327400E-01 |
| Normal-vs-Obese |
3.160500E-02 |
| Normal-vs-Extreme_Obese |
5.634400E-01 |
| Normal_Weight-vs-Extreme_Weight |
7.005800E-01 |
| Normal_Weight-vs-Obese |
2.631600E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.703000E-01 |
| Extreme_Weight-vs-Obese |
4.500800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
9.465800E-01 |
| Obese-vs-Extreme_Obese |
6.062800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.695100E-03 |
| Normal-vs-Age(41-60Yrs) |
1.632750E-04 |
| Normal-vs-Age(61-80Yrs) |
5.720000E-01 |
| Normal-vs-Age(81-100Yrs) |
5.830800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.688600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.939600E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.182400E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.762100E-04 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.392100E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.776000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.8467199999983E-05 |
| Normal-VS-Type2 PRCC |
8.180300E-03 |
| Normal-VS-KIRP CIMP |
5.988000E-02 |
| Normal-VS-Unclassified PRCC |
1.194640E-01 |
| Type1 PRCC-VS-Type2 PRCC |
3.43399753077733E-11 |
| Type1 PRCC-VS-KIRP CIMP |
8.182400E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
3.497200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
6.025000E-04 |
| Type2 PRCC-VS-Unclassified PRCC |
3.302200E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
5.023400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.198000E-01 |
| Normal-vs-N1 |
1.246390E-01 |
| Normal-vs-N2 |
2.695600E-01 |
| N0-vs-N1 |
1.662410E-01 |
| N0-vs-N2 |
4.898200E-01 |
| N1-vs-N2 |
1.950750E-01 |
|
|
